These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6970959)

  • 1. T and B lymphocytes in patients with chronic active liver disease and in healthy HBsAg carriers.
    Del Vecchio-Blanco C; Balzano A; Ambrogio G; Caporaso N; Bonanno G; Dente B
    Ric Clin Lab; 1980; 10(4):619-25. PubMed ID: 6970959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of serum rosette inhibitory factors in chronic liver disease.
    Zauli D; Bianchi FB; Fusconi M; Crespi C; Pisi E
    Clin Exp Immunol; 1983 Jul; 53(1):145-50. PubMed ID: 6603304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration in cell-mediated immunity in patients with chronic active hepatitis. I. Lymphocyte subpopulations.
    Ponzetto A; Arrigoni A
    G Batteriol Virol Immunol; 1979; 72(1-6):28-32. PubMed ID: 317950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.
    Dusheiko GM; Hoofnagle JH; Cooksley WG; James SP; Jones EA
    J Clin Invest; 1983 May; 71(5):1104-13. PubMed ID: 6602149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subpopulations of T lymphocytes in patients with chronic active liver disease.
    Burrai I; Carbone A
    Ric Clin Lab; 1982; 12(3):501-6. PubMed ID: 6982500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B surface antigen and immunoglobulin M complexes in chronic carriers and patients with acute and chronic liver diseases.
    Ayoola EA; Olubuyide I
    Afr J Med Med Sci; 1989 Mar; 18(1):21-4. PubMed ID: 2545079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Functional state of the T- and B-lymphocytes in children with chronic liver diseases].
    Mantasheva VA; Mikhaĭlova ZM; Chistova LV; Shkarenkova LV
    Pediatriia; 1980 Mar; (3):19-21. PubMed ID: 6966390
    [No Abstract]   [Full Text] [Related]  

  • 8. Antigen specific suppressor T cells from chronic hepatitis B virus (HBV) carriers inhibit the responsiveness to HBsAg of allogeneic high-responder lymphocytes.
    Barnaba V; Levrero M; Franco A; Zaccari C; Musca A; Balsano F
    J Clin Lab Immunol; 1985 Mar; 16(3):137-42. PubMed ID: 3162024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active rosette-forming lymphocytes in chronic hepatitis.
    Stanciu L; Urcan S; Părău N; Radu D; Popescu S
    Med Interne; 1982; 20(4):277-82. PubMed ID: 6985551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
    Gessoni G; Manoni F
    Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal lymphocyte interferon production in adult HBsAg-positive chronic active liver disease.
    Ponzetto A; Zucca M; Marcucci F; Rizzetto M; Actis GC; Bonino F; Gioannini P
    J Med Virol; 1979; 4(1):43-50. PubMed ID: 528984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus.
    Hadziyannis SJ; Lieberman HM; Karvountzis GG; Shafritz DA
    Hepatology; 1983; 3(5):656-62. PubMed ID: 6618432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. e System and intrahepatocelullar HBcAG and HBsAG in HBsAG positive patients with liver diseases and healthy carriers.
    Hess G; Nielsen JO; Arnold W; Büschenfelde KH
    Scand J Gastroenterol; 1977; 12(3):325-30. PubMed ID: 866995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell subsets in the hyporesponsiveness to hepatitis B surface antigen (HBsAg) and antigen-specific suppressor lymphocytes in chronic hepatitis B virus (HBV) infection.
    Barnaba V; Levrero M; Van Dyke AD; Musca A; Cordova C; Balsano F
    Clin Immunol Immunopathol; 1985 Mar; 34(3):284-95. PubMed ID: 2578908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of delta antigen in liver biopsies of HBsAg positive patients with chronic liver diseases living in the Naples area.
    Picciotto L; Abrescia N; Ciampi R
    Boll Soc Ital Biol Sper; 1983 Jan; 59(2):189-91. PubMed ID: 6860493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological evaluation of asymptomatic carriers of hepatitis B virus.
    Levo Y; Shouval D; Tur-Kaspa R; Wollner S; Penchas S; Zlotnick A; Eliakim M
    Clin Exp Immunol; 1981 Apr; 44(1):63-7. PubMed ID: 6973434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating B and T lymphocytes in chronic active liver disease.
    Fehér J; Jakab L; Pozsonyi T; Papp G
    Acta Med Acad Sci Hung; 1978; 35(1):47-52. PubMed ID: 310622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis b virus infection.
    Alberti A; Realdi G; Bortolotti F; Rigoli AM
    Gut; 1977 Dec; 18(12):1004-9. PubMed ID: 304824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells.
    Akbar SM; Abe M; Masumoto T; Horiike N; Onji M
    J Hepatol; 1999 May; 30(5):755-64. PubMed ID: 10365798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneoscopic liver biopsy findings in asymptomatic chronic HBsAg carriers with normal liver function tests and no hepatomegaly.
    Chon CY; Han KH; Lee KS; Moon YM; Kang JK; Park IS; Park C
    Yonsei Med J; 1996 Oct; 37(5):295-301. PubMed ID: 8997161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.